拉斯穆森动脉瘤在一个肺结核患者
Salman Ahmed Malik1, Allahdad Khan2, Humaira Siddique3
1Department of Pulmonology Nishtar Medical University Multan Pakistan.
Respirology case reports
|December 10, 2024
概括
拉斯穆森动脉瘤是一种罕见的结核病并发症,可以导致致命的出血. 及时识别和内血管栓塞对于治疗结核病患者这种危及生命的血栓塞至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 血管外科 血管外科
- 传染性疾病 传染性疾病
背景情况:
- 拉斯穆森动脉瘤是一种罕见但严重的结核病 (TB) 并发症.
- 它涉及肺动脉动脉瘤与结核腔相邻的肺动脉.
- 这种情况可能导致危及生命的血栓塞.
研究的目的:
- 为了突出拉斯穆森动脉瘤在结核病患者中的关键性质.
- 强调迅速诊断和干预的必要性.
- 讨论血管内栓塞作为一种关键的治疗方式.
主要方法:
- 关于拉斯穆森动脉瘤和结核病的文献综述.
- 对病例报告和临床指南的分析.
- 专注于诊断标准和干预技术.
主要成果:
- 拉斯穆森动脉瘤带来了大规模血栓塞的重大风险.
- 结核病患者的突然或严重的血栓塞需要立即接受医疗照顾.
- 内血管栓塞是一种有效的干预措施,用于控制出血.
结论:
- 早期发现和治疗拉斯穆森动脉瘤对于患者的生存至关重要.
- 多学科的合作对于最佳的患者结果至关重要.
- 内血管技术提供了一种最少的侵入性方法来管理这种罕见的并发症.
相关概念视频
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120


